Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Wright

Showing results (31-40 of 100) with videos related to

Pageof 10
Sort By:
Digestive Diseases and Sciences|February 1, 1987
Predictors of acute relapse of Crohn's disease. A laboratory and clinical studyJ P Wright, G O Young, N Tigler-Wybrandi
The British Journal of Surgery|October 1, 1984
Faecal occult blood testing in the detection of colorectal cancerM S Elliot, J H Levenstein, J P Wright
Proceedings. Mathematical, Physical, and Engineering Sciences|December 12, 2017
Multi-scale mechanics of granular solids from grain-resolved X-ray measurementsR C Hurley, S A Hall, J P Wright
Diseases of the Colon and Rectum|August 1, 1993
Incidence of surgical resection for Crohn's diseaseP A Goldberg, J P Wright, M Gerber, et al.
Inflammatory Bowel Diseases|January 4, 2013
A randomized, double-blind, placebo-controlled trial of olsalazine for active Crohn's diseaseJ P Wright, D P Jewell, R Modigliani, et al.
Journal of Clinical Gastroenterology|June 1, 1986
Peptic ulcer. A follow-up studyL Bank, J P Wright, W Lucke, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|August 19, 1989
Medium-term follow-up of Crohn's disease in Cape TownE A O'Keefe, J P Wright, J Froggatt, et al.
Digestive Diseases and Sciences|May 1, 1992
PEG-400 excretion in patients with Crohn's disease, their first-degree relatives, and healthy volunteersD Ruttenberg, G O Young, J P Wright, et al.
Digestive Diseases and Sciences|October 1, 1993
Olsalazine in maintenance of clinical remission in patients with ulcerative colitisJ P Wright, E A O'Keefe, L Cuming, et al.
Clinical Chemistry|October 17, 2012
Removal of 3-epi-25-hydroxyvitamin D(3) interference by liquid chromatography-tandem mass spectrometry is not required for the measurement of 25-hydroxyvitamin D(3) in patients older than 2 yearsMichael J P Wright, David J Halsall, Brian G Keevil
Pageof 10

Showing results (31-40 of 100) with videos related to

Sort By:
Pageof 10
Digestive Diseases and Sciences|February 1, 1987
Predictors of acute relapse of Crohn's disease. A laboratory and clinical studyJ P Wright, G O Young, N Tigler-Wybrandi
The British Journal of Surgery|October 1, 1984
Faecal occult blood testing in the detection of colorectal cancerM S Elliot, J H Levenstein, J P Wright
Proceedings. Mathematical, Physical, and Engineering Sciences|December 12, 2017
Multi-scale mechanics of granular solids from grain-resolved X-ray measurementsR C Hurley, S A Hall, J P Wright
Diseases of the Colon and Rectum|August 1, 1993
Incidence of surgical resection for Crohn's diseaseP A Goldberg, J P Wright, M Gerber, et al.
Inflammatory Bowel Diseases|January 4, 2013
A randomized, double-blind, placebo-controlled trial of olsalazine for active Crohn's diseaseJ P Wright, D P Jewell, R Modigliani, et al.
Journal of Clinical Gastroenterology|June 1, 1986
Peptic ulcer. A follow-up studyL Bank, J P Wright, W Lucke, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|August 19, 1989
Medium-term follow-up of Crohn's disease in Cape TownE A O'Keefe, J P Wright, J Froggatt, et al.
Digestive Diseases and Sciences|May 1, 1992
PEG-400 excretion in patients with Crohn's disease, their first-degree relatives, and healthy volunteersD Ruttenberg, G O Young, J P Wright, et al.
Digestive Diseases and Sciences|October 1, 1993
Olsalazine in maintenance of clinical remission in patients with ulcerative colitisJ P Wright, E A O'Keefe, L Cuming, et al.
Clinical Chemistry|October 17, 2012
Removal of 3-epi-25-hydroxyvitamin D(3) interference by liquid chromatography-tandem mass spectrometry is not required for the measurement of 25-hydroxyvitamin D(3) in patients older than 2 yearsMichael J P Wright, David J Halsall, Brian G Keevil
Pageof 10